Literature DB >> 32578517

Multiple primary malignancies involving lung cancer: a single-center experience.

Luigi Ventura1, Paolo Carbognani1, Letizia Gnetti2, Maurizio Rossi3, Marcello Tiseo4, Enrico Maria Silini2, Nicola Sverzellati5, Mario Silva5, Marcello Succi6, Cesare Braggio1, Sara Cattadori1, Giovanni Bocchialini1, Valeria Balestra1, Michele Rusca1, Luca Ampollini1.   

Abstract

OBJECTIVE: Currently, unlike earlier years, patients affected by multiple primary malignancies (MPM) are significantly increased, thus representing a clinical-pathologic category worthy of attention. Their clinical features and prognosis still need to be studied thoroughly, and this is the aim of our study.
METHODS: Patients with MPM involving lung cancer admitted in our center between January 2006 and December 2016 were considered. Parametric and nonparametric testing was used for statistical comparisons. Univariate and multivariate analysis was used to evaluate the variables associated with a prognostic value.
RESULTS: MPM incidence was 19.8%. Among the 222 patients with MPM enrolled, 204 (91.8%) had two malignancies, while 18 (8.2%) had three malignancies, 38 (17.1%) were synchronous, 41 (18.5%) had lung cancer first (LCF) and 181 (81.5%) had other cancer first (OCF). A significant difference between the time of first cancer diagnosis to the second cancer diagnosis in the LCF vs OCF group was found (median 32 vs 51 months; p-value: 0.038). The most frequent anatomical sites of malignancies preceding or following lung cancer were prostate, colorectal, bladder, and larynx. Multivariate analysis revealed that sex, histologic pattern, and time and order of occurrence were independent factors for overall survival, with male sex, squamous cell lung carcinoma, synchronous and LCF MPM significantly associated with poorer overall survival.
CONCLUSIONS: Prostate, colorectal, bladder, and larynx were the most frequent anatomical sites of malignancies preceding or following lung cancer. Male sex, squamous cell lung carcinoma, synchronous and LCF MPM might be associated with poorer prognosis.

Entities:  

Keywords:  Multiple primary malignancies; clinical characteristics; lung cancer; prognosis

Mesh:

Year:  2020        PMID: 32578517     DOI: 10.1177/0300891620933678

Source DB:  PubMed          Journal:  Tumori        ISSN: 0300-8916            Impact factor:   2.098


  4 in total

1.  Metachronous Multiple Primary Carcinoma With Acute Promyelocytic Leukemia: 2 Cases Report and Literature Review.

Authors:  Cong Wang; Yamei Shen; Yuxia Zhang; Fahui Guo; Qian Li; Huahua Zhang; Xueping Han; Haitao Zhao; Zilong Yang
Journal:  Front Oncol       Date:  2022-06-08       Impact factor: 5.738

2.  Pathological and clinical features of multiple cancers and lung adenocarcinoma: a multicentre study.

Authors:  Pietro Bertoglio; Luigi Ventura; Vittorio Aprile; Maria Angela Cattoni; Dania Nachira; Filippo Lococo; Maria Rodriguez Perez; Francesco Guerrera; Fabrizio Minervini; Letizia Gnetti; Alessandra Lenzini; Francesca Franzi; Giulia Querzoli; Guido Rindi; Salvatore Bellafiore; Federico Femia; Giuseppe Salvatore Bogina; Diana Bacchin; Peter Kestenholz; Enrico Ruffini; Massimiliano Paci; Stefano Margaritora; Andrea Selenito Imperatori; Marco Lucchi; Luca Ampollini; Alberto Claudio Terzi
Journal:  Interact Cardiovasc Thorac Surg       Date:  2022-06-15

3.  [Analysis of Clinical Characteristics of Lung Cancer Combined with 
Multiple Primary Malignancies in Other Organs].

Authors:  Shuai Zhang; Zhiyun Xu; Gaochao Dong; Ming Li; Lin Xu
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2021-01-20

4.  Survival Analysis in Patients with Lung Cancer and Subsequent Primary Cancer: A Nationwide Cancer Registry Study.

Authors:  Wen-Ru Chou; Ben-Chang Shia; Yen-Chun Huang; Chieh-Wen Ho; Mingchih Chen
Journal:  J Clin Med       Date:  2022-10-08       Impact factor: 4.964

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.